Literature DB >> 1586977

Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants.

T D Schmittgen1, A Koolemans-Beynen, T E Webb, T J Rosol, J L Au.   

Abstract

In a previous study, we showed that 5-fluorouracil (FU) is active against the dimethylhydrazine-induced colon tumor in rats; a 7-day infusion of FU at 30 mg/kg daily produced 85% tumor-free cures. The present study examined the effects of FU alone and in combination with leucovorin (LV) or D-glucarate (GT) using an ex vivo system that maintained the growth of the rat colon-tumor explants on collagen gels. The labeling index (LI) was determined by the incorporation of [3H]-thymidine and autoradiography. The mean LI of the untreated control was 64.8% +/- 19.8%. The IC50, IC90, and IC95 values following a 7-day exposure to FU were 0.36, 0.75, and 1.22 microM, respectively. In comparison, the steady-state FU concentration required to produce 67% tumor-free cures in rats following a 7-day infusion is 1.54 microM. LV alone did not produce any antiproliferative effect at concentrations as high as 10 microM. The addition of LV at concentrations of 0.001-10 microM did not significantly reduce the IC50 of FU. The lack of effect of LV may have been due to tissue saturation with folate provided in the culture medium. GT alone reduced the tumor LI by 20%-30% at concentrations of 0.1-10 microM. GT enhanced the effect of FU. As compared with FU alone, the addition of GT at concentrations of 0.1 and 1.0 microM reduced the IC50 of FU by 47% and 60% to 0.21 and 0.16 microM, respectively. Assessment of the potentiation of the inhibitory effect of FU by GT using two-way analysis of variance and the isobologram method indicated a significant synergistic interaction between FU and GT. This interaction occurred within the FU concentration range of 0.08 and 0.4 microM. In summary, these data indicate that (a) the IC values for FU are comparable in tumor explants and in rats, suggesting that the effects in cultured tumors reflect those in intact animals; (b) GT alone showed antitumor activity, albeit relatively minor as compared with FU; (c) FU and GT exhibited synergistic activity, which was most pronounced at FU concentrations that produced submaximal activity (less than 30% inhibition of tumor LI); and (d) GT and LV had different effects on the growth inhibition by FU, suggesting that GT acts by a mechanism different from the thymidylate synthase-directed effect of FU and LV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586977     DOI: 10.1007/bf00686481

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  27 in total

1.  The preparation and properties of beta-glucuronidase. IV. Inhibition by sugar acids and their lactones.

Authors:  G A LEVVY
Journal:  Biochem J       Date:  1952-11       Impact factor: 3.857

2.  Synergistic interaction between 13-cis-retinoic acid and glucarate: activity against rat mammary tumor induction and MCF-7 cells.

Authors:  H Abou-Issa; A Koolemans-Beynen; J P Minton; T E Webb
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

3.  Biological activities of 5-fluorouracil and its prodrug 5'-deoxy-5-fluorouridine in rats.

Authors:  J L Au; Y M Rustum; H K Slocum
Journal:  Cancer Drug Deliv       Date:  1987

4.  Influence of ribose donors on the action of 5-fluorouracil.

Authors:  D Kessel; T C Hall
Journal:  Cancer Res       Date:  1969-10       Impact factor: 12.701

5.  Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinoma.

Authors:  J L Grem; D D Shoemaker; N J Petrelli; H O Douglass
Journal:  Cancer Treat Rep       Date:  1987-11

Review 6.  Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid.

Authors:  J L Grem; D F Hoth; J M Hamilton; S A King; B Leyland-Jones
Journal:  Cancer Treat Rep       Date:  1987-12

7.  Nucleotide formation as adeterminant of 5-fluorouracil response in mouse leukemias.

Authors:  D Kessel; T C Hall; I Wodinsky
Journal:  Science       Date:  1966-11-18       Impact factor: 47.728

8.  Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.

Authors:  J A Houghton; L G Williams; S S de Graaf; P J Cheshire; J H Rodman; D C Maneval; I W Wainer; P Jadaud; P J Houghton
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

9.  Evidence from rat hepatocytes of an unrecognized pathway of 5-fluorouracil metabolism with the formation of a glucuronide derivative.

Authors:  J P Sommadossi; D S Cross; D A Gewirtz; I D Goldman; J P Cano; R B Diasio
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

10.  In vivo-like growth of human tumors in vitro.

Authors:  A E Freeman; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.